Disclosure under Chapter 9, Section 5 of the Finnish

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act

BIOTIE THERAPIES CORP.             STOCK EXCHANGE RELEASE       April 12, 2016 at 4.15 p.m.

Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act

Biotie Therapies Corp. (Nasdaq Helsinki BTH1V; NASDAQ: BITI) ("Biotie" or the "Company") has on April 11, 2016 received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Versant Ventures V, LLC on behalf of itself and Versant Venture Capital V, L.P.

According to the notification, the total number of Biotie shares owned directly or through financial instruments by Versant Ventures V, LLC and its funds has fallen below the threshold of 5 per cent on 11 April, 2016. Biotie's registered total number of shares and voting rights amounting to 1,089,608,083 has been used in the calculation of percentages for the announcement.

Total positions of Versant Ventures V, LLC and its funds subject to the notification:

  % of shares and voting rights (total of A) % of shares and voting rights through financial instruments (total of B) Total of both in % (A+B)
Resulting situation on the date on which threshold was crossed or reached Below 5 % Below 5 % Below 5 %
Position of previous notification (if applicable) 5.39 3.41 8.80

Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Shares and voting rights

Class/type of shares ISIN code (if possible) Number of shares and voting rights % of shares and voting rights
Direct (SMA 9:5)   Indirect (SMA 9:6 and 9:7) Direct (SMA 9:5) Indirect (SMA 9:6 and 9:7)
Shares (FI0009011571) - - - -
American Depositary Shares (ADS), each representing 80 Shares (FI0009011571) - - - -
         
SUBTOTAL A   Below 5 %

B: Financial instruments according to SMA 9:6a

Type of financial instrument Expiration date Exercise/ Conversion period Physical or cash settlement Number of shares and voting rights % of shares and voting rights
Warrants entitling to subscribe for Shares (FI0009011571) Nov 1, 2020 Nov 1, 2015 - Nov 1, 2020 Physical settlement - -
           
      SUBTOTAL B   Below 5 %

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name % of shares and voting rights % of shares and voting rights through financial instruments Total of both
Versant Ventures V, LLC Below 5 % Below 5 % Below 5 %
Versant Venture Capital V, L.P. Below 5 % Below 5 % Below 5 %
Versant Affiliates Fund V, L.P. Below 5 % Below 5 % Below 5 %
Versant Ophthalmic Affiliates Fund I, L.P. Below 5 % Below 5 % Below 5 %
Versant Ventures V GP-GP (Canada), Inc. Below 5 % Below 5 % Below 5 %
Versant Ventures V (Canada), L.P. Below 5 % Below 5 % Below 5 %
Versant Venture Capital V (Canada) LP Below 5 % Below 5 % Below 5 %

According to the notification, Versant Ventures V, LLC is the sole general partner of (i) Versant Venture Capital V, L.P. (ii) Versant Affiliates Fund V, L.P. and (iii) Versant Ophthalmic Affiliates Fund I, L.P. and (iv) the sole shareholder of Versant Ventures V GP-GP (Canada), Inc. Versant Ventures V GP-GP (Canada), Inc. is the sole general partner of Versant Ventures V (Canada), L.P., which is the sole general partner of Versant Venture Capital V (Canada) LP. Neither Versant Ventures V, LLC nor any other entity under its control holds shares or financial instruments in the Company exceeding a notification threshold. Further, according to the notification, the investments of the Versant Venture III funds (controlled by Versant Ventures III, LLC) are under the Finnish Securities Markets Act not to be aggregated with the investments of the funds controlled by Versant Ventures V, LLC for the purposes of this notification.

In Turku, April 12, 2016

Biotie Therapies Corp.

Timo Veromaa President and CEO

For further information, please contact:

Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp. tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

DISTRIBUTION:

Nasdaq Helsinki Ltd Main Media www.biotie.com

HUG#2002851

Scroll down for more posts ▼

Top 10 Most Recent News Articles

XKIG Bolsters Northwest with Jensen's Acquisition

Updated Category News Views 44

Stepping Up the Game in the Pacific Northwest Well, here we see another classic example of a shrewd move in the infrastructure sector. XKIG, a name known to those who keep an eye on critical infrastructure services for utilities, has decided to widen its footprint with a strategic grab of Jensen's Tree Service, Inc. They’re setting up shop even deeper in the Pacific...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 193

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 85

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 74

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 104

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 246

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 88

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading

Top 5 Most Recently Viewed Articles

RegScale Secures FedRAMP High Authorization: A Game-Changer

Updated Category News Views 263

RegScale Secures FedRAMP High Authorization RegScale, utilizing its innovative Continuous Controls Monitoring platform, has reached the notable milestone of obtaining FedRAMP High Authorization, demonstrating a significant advancement in compliance and risk management within the government sector. This achievement showcases RegScale's commitment to enhancing security...

Continue Reading
SiriusXM Improves Financial Guidance Amid Digital Growth

Updated Category News Views 214

SiriusXM Holdings Inc Experiences Stock Surge SiriusXM Holdings Inc (NASDAQ:SIRI) saw its stock prices climb significantly following the release of its fiscal third-quarter results. Investors responded positively as the company’s future outlook showed promise for expansion. Positive Financial Results The report revealed a subscriber revenue of $1.63 billion for the...

Continue Reading
Explore Top Free AI Image Translators for Your Needs

Updated Category News Views 288

Unlocking the Power of Image Translation Translating text from images is a crucial task in today’s digital world. Whether you need to read signs, understand menus, interpret social media posts, or analyze product reviews, having a reliable image translator can make a significant difference. The right tools not only improve accuracy but also support multiple languages,...

Continue Reading
Exciting Collaboration Unveiled: REESE'S and OREO Join Forces

Updated Category News Views 240

An Exciting New Collaboration The anticipation has been palpable among fans of REESE'S and OREO, and now, the moment has arrived. These iconic brands, celebrated for their unique flavors, are thrilled to present a delectable collaboration that combines their most popular offerings. This partnership responds directly to the enthusiasm and demand expressed by fans....

Continue Reading
Innovative Clinical Research Enhances Care for Cancer Patients

Updated Category News Views 440

Innovative Research at Florida Cancer Specialists Clinical research at Florida Cancer Specialists & Research Institute is making significant strides in expanding treatment options for patients dealing with gastrointestinal and genitourinary cancers. This knowledgeable institute is at the forefront of developing and presenting vital research that contributes to improved...

Continue Reading